June 10, 2005 Volume 1, Number 3
 
 
Investing Time to Make Money: A PAT Implementation Perspective-By John E. Carroll
API Scale-Up During Research and Development-By Nandita P. Shetgiri, Mahesh S. Phansalkar, Sandeep Patil, and Rupesh Kelaskar
Outsourcing Outlook-Seeking a Fresh Start
Packaging Forum-New Systems for Counterfeit Protection and Quality Control
Washington Report-Drug Specifications Under Scrutiny
Contracts, Mergers, and Announcements
People
Calendar
Contact
 

Investing Time to Make Money: A PAT Implemenation Perspective
By John E. Carroll


API Scale-Up During Research and Development
By Nandita P. Shetgiri, Mahesh S. Phansalkar, Sandeep Patil, and Rupesh Kelaskar


Outsourcing Outlook
Pharmaceutical companies have various options when faced with the need to reclaim their positions in the market.


Packaging Forum
Counterfeiting prevention has joined quality control as a top concern for pharmaceutical manufacturers. Both issues were given a high profile at the recent Interphex and Interpack trade exhibitions.


Washington Report
FDA is examining the process for setting specifications as part of efforts to update GMPs and harmonize policies for ensuring drug quality and safety.

Contracts, Mergers, and Announcements

 

People

Calendar

Contact

 |  PharmTech   |
© 2005 Advanstar Communications. All rights reserved.
Reproduction in whole or in part is prohibited.   Please send any technical comments or questions to our webmaster.